Gretchen L. Temeles, Ph.D., J.D., is an experienced intellectual property (IP) attorney and scientist who assists clients in the psychedelics and cannabis space in formulating comprehensive global IP strategies to further their business goals. She also advises clients in the biotechnology, chemical, and pharmaceutical industries. Her experience includes patent portfolio management, both U.S. and international patent prosecution, patent landscape analyses, freedom-to-operate searches, IP due diligence, non-infringement and invalidity opinions, trade secret analyses, European opposition proceedings, and transactional work, including material transfer agreements, sponsored research agreements and licensing agreements. Prior to her work in the legal field, Dr. Temeles spent seven years at an early-stage biotech startup, so she has first-hand experience with the challenges facing emerging companies. In addition, her experience spans multiple industry sectors, including investors, specialty chemical companies, medical device companies, midmarket biotech companies, and universities, all of which are present or future stakeholders in the burgeoning psychedelics industry.
Dr. Temeles’ experience as a scientist in the biotechnology industry is foundational to her IP practice and the practical, real-world approach she brings to solving legal problems. She was a group leader in a biotechnology company focused on small molecule drug discovery in therapeutic areas that included neurological disorders, inflammation, cancer, and infectious disease. Previously, she held research positions at the University of Pennsylvania, and Merck Sharpe and Dohme Research Laboratories. Dr. Temeles is a co-inventor on two U.S. patents and has authored peer-reviewed scientific papers. She holds degrees from Temple University Beasley School of Law (J.D.); Yale University (Ph.D., Biology); and the University of Pennsylvania (B.A., cum laude).
- Trade Secret Litigation Comes to Psychedelics
- Psychedelics: From Fungi To Plants To Patents Life Sciences IP Review
- The Next Cannabis? Patent Protection for Psychedelic Therapeutics The Legal Intelligencer – law.com